XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE RECOGNITION
9 Months Ended
Sep. 30, 2022
REVENUE RECOGNITION  
5. REVENUE RECOGNITION

NOTE 5 – REVENUE RECOGNITION

 

Products consist of the following:

 

 

·

Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide and antimony metal

 

·

Zeolite: includes coarse and fine zeolite crushed in various sizes

 

·

Precious metals: includes unrefined and refined gold and silver

 

Sales of products for the three-months ended September 30, 2022 and 2021 were as follows:

 

 

 

For the three months ended

 

 

 

September 30,

2022

 

 

September 30,

2021

 

Antimony

 

$1,671,301

 

 

$1,284,969

 

Zeolite

 

 

792,683

 

 

 

693,008

 

Precious metals

 

 

-

 

 

 

73,736

 

TOTAL REVENUE BY PRODUCT

 

$2,463,984

 

 

$2,051,713

 

 

Sales of products for the nine months ended September 30, 2022 and 2021 were as follows:

 

 

 

For the nine months ended

 

 

 

September 30,

2022

 

 

September 30,

2021

 

Antimony

 

$6,972,312

 

 

$3,371,015

 

Zeolite

 

 

2,487,116

 

 

 

1,929,383

 

Precious metals

 

 

165,183

 

 

 

280,164

 

TOTAL REVENUE BY PRODUCT

 

$9,624,611

 

 

$5,580,562

 

The Company’s trade accounts receivable balance related to contracts with customers was $1,450,314 at September 30, 2022 and $891,314 at December 31, 2021. The Company’s products do not involve any warranty agreements and product returns are not typical.

 

For the three and nine months ended September 30, 2022, the Company also received royalties related to a trademark and licensing agreement in its antimony business segment and is recognized under “Other Income”. For the three months ended September 30, 2022 and 2021, royalty income of $4,899 and $Nil, respectively was recognized. For the nine months ended September 30, 2022 and 2021, royalty income of $65,674 and $Nil, respectively was recognized